Drupal.behaviors.print = function(context) {window.print();window.close();}>
Metamark Genetics Completes $13M Series B Round as President and CEO Resigns
November 05, 2012
Metamark Genetics Completes $13M Series B Round as President and CEO Resigns
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Cancer Dx Firm Metamark Genetics Raises $22M
July 13, 2010 / GenomeWeb Daily News
Stat-Diagnostica Raises $22.1M in Private Financing Round
May 6, 2013 / GenomeWeb Daily News
GenomeDx, Mayo Clinic Expand Research Deal
April 29, 2013 / GenomeWeb Daily News
MDx Firm Curetis Raises $16.3M in Series B Round
April 22, 2013 / GenomeWeb Daily News
Prostate Cancer Risk Markers Show Promise for Test to ID Elevated Risk in Men with Benign Hyperplasia
April 3, 2013 / Pharmacogenomics Reporter